Statute Details
- Title: Goods and Services Tax (Imports Relief) Order
- Act Code: GSTA1993-OR3
- Type: Subsidiary legislation (SL)
- Current status: Current version as at 27 Mar 2026
- Authorising Act: Goods and Services Tax Act (Chapter 117A, Sections 24(1), (2) and (3) and 86(1))
- Key provisions: Section 2 (definitions); Section 3 (certificates/permits); Section 4 (relief granted); Section 5 (determination of value)
- Schedule: Lists eligible organisations/persons, specified goods, conditions, and required documents/certificates/permits
- Legislative history (high level): Substantially amended over time, including amendments by S 506/2020 (w.e.f. 01/07/2020) and later updates through 2025 (S 213/2025 w.e.f. 01/04/2025)
What Is This Legislation About?
The Goods and Services Tax (Imports Relief) Order (“Imports Relief Order”) is a Singapore subsidiary law that creates targeted exemptions from Goods and Services Tax (GST) on certain imports. In practical terms, it allows specified organisations or persons to import particular categories of goods without paying GST at the point of importation—provided they meet the conditions and documentary requirements set out in the Order’s Schedule.
This is not a general GST “holiday” for all importers. Instead, the relief is narrow and structured: eligibility depends on (i) who is importing, (ii) what goods are being imported (as itemised in the Schedule), and (iii) whether the importer satisfies the conditions and submits the required certificates/permits (or security) to the proper customs officer.
The Order also contains an important “anti-avoidance” clarification on valuation. Where the value of imported goods must be determined for purposes of applying the Schedule, the Order instructs decision-makers not to take into account the value of goods whose import is exempt. This helps prevent manipulation of valuation outcomes by mixing exempt and non-exempt goods for the same import transaction.
What Are the Key Provisions?
Section 2 (Definitions): Section 2 supplies definitions used throughout the Order. While many definitions track concepts in the Customs Act (such as “customs territory”, “dutiable goods”, “proper officer of customs”, and “senior officer of customs”), the Order also defines specialised terms relevant to regulated goods. For example, it defines “medicinal product” by reference to the Medicines Act, and “therapeutic product” by reference to the Health Products Act. It also defines “regulated clinical trial” and “protocol” in the context of clinical trials authorised or notified under the relevant Health Sciences Authority frameworks.
From a practitioner’s perspective, these cross-references matter because eligibility for imports relief often turns on whether the goods fall within a regulated category (e.g., therapeutic products or medicinal products) and whether the importer’s activity is within a regulated clinical trial framework. If the underlying regulatory classification is wrong, the GST relief may fail even if the importer otherwise holds permits.
Section 3 (Certificates to be produced): Section 3 sets the procedural timing rule. Any certificate or permit required by the Order must be produced to the proper officer of customs at the time of customs clearance of the goods. This is a strict “at clearance” requirement: it is not enough to have the document later, and it is not enough to merely apply for it. Customs clearance is the operational checkpoint where the relief is assessed and GST treatment is applied.
Section 4 (Relief granted): Section 4 is the heart of the Order. It provides that the organisations or persons specified in the second column of the Schedule are granted relief from payment of GST on the importation of goods specified in the third column, subject to multiple safeguards.
Under Section 4(1), relief is granted only if all of the following are satisfied:
- Conditions in the Schedule: The importer must comply with the conditions specified in the fourth column.
- Submission of documents/certificates/permits: The importer must submit the document, certificate or permit specified in the fifth column, in the form and manner the Director-General may determine.
- Security: The importer must furnish security in the amount the Director-General requires.
- Further revenue-protection conditions: The Director-General may impose any further condition for the protection of revenue.
Section 4(2) adds flexibility: the Director-General may waive the requirement to submit a document/certificate/permit under Section 4(1)(b) if he considers it expedient. Practically, this can be relevant where documents are difficult to obtain in time, where there is an administrative reason for non-submission, or where customs can verify the relevant facts through other means. However, the waiver is discretionary, so counsel should not assume it will be granted.
Section 5 (Determination of value of goods): Section 5 addresses a valuation issue “for the avoidance of doubt”. Where, for any item in the Schedule, the value of goods imported into Singapore needs to be determined, the value determination must ignore the value of any goods the import of which is an exempt import.
This provision is significant because GST relief often depends on whether the imported goods fall within a particular Schedule item and how the “value of goods” is computed. Section 5 prevents a scenario where an importer could reduce or distort the relevant valuation by including or referencing exempt goods. For practitioners, this means valuation methodology must be carefully documented and aligned with the Schedule item being relied upon, without “netting” or mixing exempt import values into the calculation.
How Is This Legislation Structured?
The Imports Relief Order is structured as a short operative instrument supported by a Schedule. The main sections are:
- Section 1 (Citation): Provides the short title.
- Section 2 (Definitions): Defines key terms, including those cross-referenced to the Customs Act, Medicines Act, Health Products Act, and clinical trial regulations.
- Section 3 (Certificates to be produced): Establishes the timing and recipient of required documents—produced to the proper officer of customs at the time of customs clearance.
- Section 4 (Relief granted): Sets out the relief mechanism and conditions, including documentary submission, security, and Director-General discretion.
- Section 5 (Determination of value of goods): Clarifies how valuation should be treated when exempt imports are involved.
The Schedule is the operational core. It typically works as a matrix: the second column identifies eligible organisations/persons; the third column lists the goods; the fourth column sets conditions; and the fifth column specifies the documents/certificates/permits required. Because the Schedule is where the “who/what/conditions/document” details live, practitioners must read the Schedule item-by-item rather than relying on general descriptions.
Who Does This Legislation Apply To?
The Order applies to organisations or persons specified in the Schedule who import goods specified in the Schedule. In other words, it is not a universal relief for all importers; it is conditional and beneficiary-specific. If an importer is not listed in the Schedule for the relevant goods, the GST relief will not apply.
In addition, the Order applies only when the importer seeks to rely on the relief mechanism and complies with the procedural requirements—especially producing the required certificates/permits at customs clearance, furnishing security, and meeting the Schedule conditions. The definitions in Section 2 indicate that the relief may be relevant to regulated sectors (such as medicinal or therapeutic products and regulated clinical trials), but the precise scope depends on the Schedule’s entries.
Why Is This Legislation Important?
This Order is important because it provides a legally structured pathway to reduce or eliminate GST payable on certain imports—often a material cost driver for businesses and institutions dealing with regulated goods. For example, where goods are imported for legitimate regulated purposes (such as clinical trials or therapeutic/medicinal contexts), the relief can improve cash flow and reduce upfront tax burdens, provided the importer can satisfy customs and regulatory documentation requirements.
From an enforcement and compliance standpoint, the Order is also a reminder that GST treatment at import is highly document-driven. Section 3’s “at customs clearance” requirement means that importers must operationalise compliance: ensure permits and certificates are available, correctly issued, and presented to customs at the right time. Failure to do so can result in GST being assessed and payable, potentially undermining the relief claim.
Finally, Section 5’s valuation clarification is a practical safeguard against manipulation. It affects how importers and customs brokers should prepare declarations and valuation support. Practitioners should ensure that valuation calculations are aligned with the specific Schedule item and that exempt import values are not improperly included in the determination of value for the relief item.
Related Legislation
- Goods and Services Tax Act (Cap. 117A) (authorising provisions: Sections 24(1), (2) and (3) and 86(1))
- Customs Act (Cap. 70) (definitions and customs administration concepts)
- Health Products Act (Cap. 122D) (definitions relevant to therapeutic products and certain clinical trial frameworks)
- Medicines Act (Cap. 176) (definition of “medicinal product”)
- Health Products (Clinical Trials) Regulations 2016 (referenced for “regulated clinical trial” and related authorisation/notification)
- Medicines (Clinical Trials) Regulations 2016 (referenced for clinical trial certificate issuance)
Source Documents
This article provides an overview of the Goods and Services Tax (Imports Relief) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.